Genetic susceptibility to head and neck squamous cell carcinoma

Journal of the National Cancer Institute

Volumn 88, Issue 8, 1996, Pages 530-535

  Cloos, Jacqueline ^a   Spitz, Margaret R ^c   Schantz, Stimson P ^d   Hsu, T C ^c   Zhang, Zuo Feng ^d   Tobi, Hilde ^b   Braakhuis, Boudewijn J M ^a   Snow, Gordon B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF TEXAS   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTAGENIC AGENT;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENETIC SUSCEPTIBILITY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUTAGEN TESTING; MUTAGENESIS; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; ETHANOL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUTAGENS; SMOKING;

EID: 0029922149     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.8.530     Document Type: Article

References (35)

1. Baron AE, Franceschi S, Barra S, Talamini R, La Vecchia C. A comparison of the joint effects of alcohol and smoking on the risk of cancer across sites in the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 1993;2:519-23.
2. Li FP. Montesano R. Interactions of cancer susceptibility genes and environmental carcinogens. American Association for Cancer Research (AACR) - International Agency for Research on Cancer (IARC) Joint Conference. Cancer Res 1994;54:4243-7.
3. Hsu TC Genetic instability in the human population: a working hypothesis. Hereditas 1983;98:1-9.
4. Spitz MR, Bondy ML. Genetic susceptibility to cancer. Cancer 1993;72(3 Suppl):991-5.
5. Spitz MR, Hsu TC, Wu X, Fueger JJ, Amos CI, Roth JA. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev 1995;4:99-103.
6. Harris CC. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res 1991;51(18 Suppl):5023s-44s.
7. Spitz MR, Fueger JJ, Halabi S, Schantz SP, Sample D, Hsu TC. Mutagen sensitivity in upper aerodigestive tract cancer, a case-control analysis. Cancer Epidemiol Biomarkers Prev 1993;2:329-33.
8. Cloos J, Braakhuis BJ, Steen I, Copper MP, de Vries N, Nauta JJ, et al. Increased mutagen sensitivity in head-and-neck squamous-cell carcinoma patients, particularly those with multiple primary tumors. Int J Cancer 1994;56:816-9.
9. Hsu TC. Genetic predisposition to cancer with special reference to mutagen sensitivity. In Vitro Cell Dev Biol 1987;23:591-603.
10. Cloos J, Steen I, Joenje H, Ko JY, de Vries N, van der Sterre ML, et al. Association between bleomycin genotoxicity and non-constitutional risk factors for head and neck cancer. Cancer Lett 1993;74.161-5.
11. Hsu TC, Johnston DA, Cherry LM, Ramkissoon D, Schantz SP, Jessup JM, et al. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 1989;43:403-9.
12. Ponder BA. Inherited predisposition to cancer. Trends Genet 1990;6 213-8.
13. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, et al A single ataxia telangiectasia gene with a product similar to PI-3 kinase [see comment citation in Medline]. Science 1995;268:1749-53.
14. Meyn MS Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res 1995;55:5991-6001.
15. Sanford KK, Parshad R, Price FM, Jones GM, Tarone RE, Eierman L, et al. Enhanced chromatid damage in blood lymphocytes after G2 phase x irradiation, a marker of the ataxia-telangiectasia gene. J Natl Cancer Inst 1990;82:1050-4.
16. Scott D, Spreadborough A, Levine E, Roberts SA. Genetic predisposition in breast cancer [letter]. Lancet 1994;344:1444.
17. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telangiectasia [see comment citations in Medline]. N Engl J Med 1991;325:1831-6.
18. Digweed M. Human genetic instability syndromes: single gene defects with increased risk of cancer. Toxicol Lett 1993;67:259-81.
19. Sanford KK, Parshad R, Gantt RR, Tarone RE. A deficiency in chromatin repair, genetic instability, and predisposition to cancer. Crit Rev Oncog 1989;1:323-41.
20. Pandita TK, Hittelman WN. Evidence for a chromatin basis for increased mutagen sensitivity associated with multiple primary malignancies of the head and neck. Int J Cancer 1995:61:738-43.
21. Hecht SS. Environmental tobacco smoke and lung cancer: the emerging role of carcinogen biomarkers and molecular epidemiology [editorial; comment] [see comment citation in Medline]. J Natl Cancer Inst 1994;86: 1369-70.
22. Caporaso N, Goldstein A. Cancer genes: single and susceptibility: exposing the difference. Pharmacogenetics 1995;5:59-63.
23. Hsu TC, Spitz MR, Schantz SP. Mutagen sensitivity: a biological marker of cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1991;1:83-9.
24. Maier H, Dietz A, Gewelke U, Heller WD, Weidauer H. Tobacco and alcohol and the risk of head and neck cancer. Clin Investig 1992;70:320-7.
25. Hsu TC, Furlong C. The role of ethanol in oncogenesis of the upper aerodigestive tract; inhibition of DNA repair. Anticancer Res 1991;11: 1995-8.
26. Copper MP, Jovanovic A, Nauta JJ, Braakhuis BJ, de Vries N, van der Waal I, et al. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1995;121:157-60.
27. Spitz MR, Hoque A, Trizna Z, Schantz SP, Amos CI, King TM, et al. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract [see comment citations in Medline]. J Natl Cancer Inst 1994;86:1681-4.
28. Schantz SP, Spitz MR, Hsu TC. Mutagen sensitivity in patients with head and neck cancers. a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst 1990;82:1773-5.
29. Snow GB. Follow-up in patients treated for head and neck cancer: how frequent, how thorough and for how long? Eur J Cancer 1992;28:315-6.
30. Lippman SM, Spitz M, Trizna Z, Benner SE, Hong WK. Epidemiology, biology, and chemoprevention of aerodigestive cancer. Cancer 1994;74(9 Suppl):2719-25.
31. Dave BJ, Hsu TC, Hong WK, Pathak S. Nonrandom distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies. Int J Oncol 1994;5:733-40.
32. Wu XF, Hsu TC, Annegers JF, Amos CI, Fueger JJ, Spitz MR. A casecontrol study of non-random distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. Cancer Res 1995;55:557-61.
33. Wei Q, Spitz MR, Gu J, Cheng L, Xu X, Strom SS, et al. DNA repair correlates with mutagen sensitivity in lymphoblastoid cell lines. Cancer Epidemiol Biomarkers Prev. In press.
34. Powell S, Whitaker S, Peacock J, McMillan T. Ataxia telangiectasia: an investigation of the repair defect in the cell line AT5BIVA by plasmid reconstruction. Mutat Res 1993;294:9-20.
35. Brogger A, Hagmar L, Hansteen IL, Heim S, Hogstedt B, Knudsen L, et al An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Nordic Study Group on the Health Risk of Chromosome Damage. Cancer Genet Cytogenet 1990;45:85-92.